Press Release
September 3, 2020
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
More
August 6, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
More
July 30, 2020
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
More
June 19, 2020
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
More
June 12, 2020
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
More
June 9, 2020
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
More
June 2, 2020
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
More
May 7, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
More
May 4, 2020
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
More
April 27, 2020